HomeBUSINESS
BUSINESS

Astellas Snapping Up US Mitochondrial Disease Specialist Mitobridge
(Dec.5.2017)

Astellas Pharma has exercised its exclusive option to acquire US startup Mitobridge, formerly known as Mitokyne, under the amended terms of their R&D partnership pact in 2013 focusing on mitochondrial disease therapies, the two companies said on November 30 ...
(LOG IN FOR FULL STORY)